{"entity":{"type":"insider","cik":"0001430354","url":"/insider/0001430354","json_url":"/insider/0001430354.json","name":"ROSENDALE MARTIN P","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":10,"first":"2008-04-03","last":"2014-08-21","span_basis":"filed_date"},"name_variants":[{"name":"ROSENDALE MARTIN P","source":"filing","n_filings":10,"first_seen":"2008-04-03","last_seen":"2014-08-21"}],"transactions":[{"id":7048872,"accession":"0001144204-14-051968","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-051968","line_url":"/filing/0001144204-14-051968#line-1","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"CYTOMEDIX INC","issuer_ticker":"CMXI","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":"0001430354","owner_name":"ROSENDALE MARTIN P","owner_display_name":"ROSENDALE MARTIN P","owner_url":"/insider/0001430354","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":0.4,"price_display":"0.40","price_state":"stated","total_value":10000.0,"total_display":"10,000.00","total_whole":"10,000","shares_owned_after":229149.0,"shares_owned_after_display":"229,149","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-20","filed_date":"2014-08-21","scope":"insider"},{"id":5502643,"accession":"0001144204-13-020386","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-13-020386","line_url":"/filing/0001144204-13-020386#line-1","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"CYTOMEDIX INC","issuer_ticker":"CMXI","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":"0001430354","owner_name":"ROSENDALE MARTIN P","owner_display_name":"ROSENDALE MARTIN P","owner_url":"/insider/0001430354","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17231.0,"shares_display":"17,231","price_per_share":0.52,"price_display":"0.52","price_state":"stated","total_value":8960.12,"total_display":"8,960.12","total_whole":"8,960","shares_owned_after":204149.0,"shares_owned_after_display":"204,149","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-04","filed_date":"2013-04-05","scope":"insider"},{"id":4904003,"accession":"0001144204-13-010665","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-13-010665","line_url":"/filing/0001144204-13-010665#line-1","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"CYTOMEDIX INC","issuer_ticker":"CMXI","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":"0001430354","owner_name":"ROSENDALE MARTIN P","owner_display_name":"ROSENDALE MARTIN P","owner_url":"/insider/0001430354","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.53,"price_display":"0.53","price_state":"stated","total_value":10600.0,"total_display":"10,600.00","total_whole":"10,600","shares_owned_after":186918.0,"shares_owned_after_display":"186,918","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-22","filed_date":"2013-02-22","scope":"insider"},{"id":2406626,"accession":"0001144204-12-037940","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-12-037940","line_url":"/filing/0001144204-12-037940#line-1","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"CYTOMEDIX INC","issuer_ticker":"CMXI","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":"0001430354","owner_name":"ROSENDALE MARTIN P","owner_display_name":"ROSENDALE MARTIN P","owner_url":"/insider/0001430354","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":1.15,"price_display":"1.15","price_state":"stated","total_value":9200.0,"total_display":"9,200.00","total_whole":"9,200","shares_owned_after":158251.0,"shares_owned_after_display":"158,251","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-03","filed_date":"2012-07-03","scope":"insider"},{"id":9077506,"accession":"0001144204-11-018899","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-11-018899","line_url":"/filing/0001144204-11-018899#line-1","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"CYTOMEDIX INC","issuer_ticker":"CMXI","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":"0001430354","owner_name":"ROSENDALE MARTIN P","owner_display_name":"ROSENDALE MARTIN P","owner_url":"/insider/0001430354","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.36,"price_display":"0.36","price_state":"stated","total_value":7200.0,"total_display":"7,200.00","total_whole":"7,200","shares_owned_after":90573.0,"shares_owned_after_display":"90,573","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-31","filed_date":"2011-03-31","scope":"insider"},{"id":5669907,"accession":"0001144204-09-043681","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-09-043681","line_url":"/filing/0001144204-09-043681#line-1","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"CYTOMEDIX INC","issuer_ticker":"GTF","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":"0001430354","owner_name":"ROSENDALE MARTIN P","owner_display_name":"ROSENDALE MARTIN P","owner_url":"/insider/0001430354","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17500.0,"shares_display":"17,500","price_per_share":0.57,"price_display":"0.57","price_state":"stated","total_value":9975.0,"total_display":"9,975.00","total_whole":"9,975","shares_owned_after":68534.0,"shares_owned_after_display":"68,534","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-14","filed_date":"2009-08-14","scope":"insider"},{"id":5592565,"accession":"0001144204-09-029361","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-09-029361","line_url":"/filing/0001144204-09-029361","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"CYTOMEDIX INC","issuer_ticker":"GTF","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":"0001430354","owner_name":"ROSENDALE MARTIN P","owner_display_name":"ROSENDALE MARTIN P","owner_url":"/insider/0001430354","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":0.518,"price_display":"0.52","price_state":"stated","total_value":1554.0,"total_display":"1,554.00","total_whole":"1,554","shares_owned_after":51034.0,"shares_owned_after_display":"51,034","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-22","filed_date":"2009-05-26","scope":"insider","n_lines":2},{"id":5797318,"accession":"0001144204-09-000872","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-09-000872","line_url":"/filing/0001144204-09-000872#line-1","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"CYTOMEDIX INC","issuer_ticker":"GTF","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":"0001430354","owner_name":"ROSENDALE MARTIN P","owner_display_name":"ROSENDALE MARTIN P","owner_url":"/insider/0001430354","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.39,"price_display":"0.39","price_state":"stated","total_value":1950.0,"total_display":"1,950.00","total_whole":"1,950","shares_owned_after":48334.0,"shares_owned_after_display":"48,334","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-01-07","filed_date":"2009-01-08","scope":"insider"},{"id":3538972,"accession":"0001144204-08-051822","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-08-051822","line_url":"/filing/0001144204-08-051822#line-1","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"CYTOMEDIX INC","issuer_ticker":"GTF","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":"0001430354","owner_name":"ROSENDALE MARTIN P","owner_display_name":"ROSENDALE MARTIN P","owner_url":"/insider/0001430354","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":33334.0,"shares_display":"33,334","price_per_share":0.75,"price_display":"0.75","price_state":"stated","total_value":25000.5,"total_display":"25,000.50","total_whole":"25,001","shares_owned_after":43334.0,"shares_owned_after_display":"43,334","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-05","filed_date":"2008-09-09","scope":"insider"},{"id":3890089,"accession":"0001144204-08-020365","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001144204-08-020365","line_url":"/filing/0001144204-08-020365","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"CYTOMEDIX INC","issuer_ticker":"GTF","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":"0001430354","owner_name":"ROSENDALE MARTIN P","owner_display_name":"ROSENDALE MARTIN P","owner_url":"/insider/0001430354","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.85,"price_display":"0.85","price_state":"stated","total_value":8500.0,"total_display":"8,500.00","total_whole":"8,500","shares_owned_after":4800.0,"shares_owned_after_display":"4,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-04-03","filed_date":"2008-04-03","scope":"insider","n_lines":6}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":16,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001091596","name":"CYTOMEDIX INC","url":"/issuer/0001091596","role":"Director, Officer (Chief Executive Officer)","n_filings":10,"first_seen":"2008-04-03","last_seen":"2014-08-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001430354","retrieved_at":"2026-08-24T20:10:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}